Does non-steroidal anti-inflammatory (NSAID) ibuprofen induce antioxidant stress and endocrine disruption in mussel Mytilus galloprovincialis?

Environmental Toxicology and Pharmacology

Volumn 33, Issue 2, 2012, Pages 361-371

  Gonzalez Rey, Maria ^a   Bebianno, Maria João ^a  

^a UNIVERSITY OF ALGARVE   (Portugal)

Author keywords

Antioxidant enzymes; Endocrine disruption; Ibuprofen; Lipid peroxidation; Mussel; Oxidative stress

Indexed keywords

ALKALINE PHOSPHATASE; CATALASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; IBUPROFEN; SUPEROXIDE DISMUTASE;

ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CYTOGENETICS; ENDOCRINE SYSTEM; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; EXOCRINE GLAND; FEMALE; GEOGRAPHIC DISTRIBUTION; HYDROLYSIS; LIPID PEROXIDATION; MALE; MYTILUS GALLOPROVINCIALIS; NONHUMAN; OXIDATIVE STRESS; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SEX DIFFERENCE;

ALKALINE PHOSPHATASE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; BIOLOGICAL MARKERS; CATALASE; DIGESTIVE SYSTEM; ENDOCRINE DISRUPTORS; FEMALE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; GONADS; IBUPROFEN; LIPID PEROXIDATION; MALE; MYTILUS; OXIDATIVE STRESS; PRINCIPAL COMPONENT ANALYSIS; SUPEROXIDE DISMUTASE; TIME FACTORS; WATER POLLUTANTS, CHEMICAL;

MYTILUS GALLOPROVINCIALIS;

EID: 84856330841     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2011.12.017     Document Type: Article

References (85)

1. Anderson P.D., D'Aco V.J., Shanahan P., Chapra S.C., Buzby M.E., Cunningham V.L., Duplessie B.M. Screening analysis of human pharmaceutical compounds in U.S. surface waters. Environ. Sci. Technol. 2004, 38:838-849.
2. Ardaillou R., Baud L., Sraer J. Role of arachidonic acid metabolites and reactive oxygen species in glomerular immune-inflammatory process. Springer Semin. Immunopathol. 1987, 9:371-385.
3. Ashton D., Hilton M., Thomas K.V. Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Sci. Total Environ. 2004, 333:167-184.
4. Bendz D., Paxéus N.A., Ginn T.R., Loge F.J. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden. J. Hazard. Mater. 2005, 122:195-204.
5. Besse J.-P., Garric J. Human pharmaceuticals in surface waters. Implementation of a prioritization methodology and application to the French situation. Toxicol. Lett. 2008, 176(2):104-123.
6. Blaise C., Gagné F., Pellerin J., Hansen P.D. Determination of vitellogenin-like properties in Mya arenaria hemolymph (Saguenay Fjord, Canada): a potential biomarker for endocrine disruption. Environ. Toxicol. 1999, 14:455-465.
7. Bouchard B., Gagné F., Fortier M., Fournier M. An in situ study of the impacts of urban wastewater on the immune and reproductive systems of the freshwater mussel Elliptio complanata. Comp. Biochem. Physiol. C 2009, 150(2):132-140.
8. Bound J.P., Voulvoulis N. Pharmaceuticals in the aquatic environment - a comparison of risk assessment strategies. Chemosphere 2004, 56:1143-1155.
9. Bound J.P., Voulvoulis N. Predicted and measured concentrations for selected pharmaceuticals in UK rivers: Implications for risk assessment. Water Res. 2006, 40:2885-2892.
10. Bradford M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
11. Cahill J.D., Furlong E.T., Burkhardt M.R., Kolpin D., Anderson L.G. Determination of pharmaceutical compounds in surface- and ground-water samples by solid-phase extraction and high-performance liquid chromatography-electrospray ionization mass spectrometry. J. Chromatogr. A 2004, 1041:171-180.
12. Cajaraville M.P., Bebianno M.J., Porte C., Sarasquete C., Viarengo A. The use of biomarkers to assess the impact of pollution in coastal environments of the Iberian Peninsula: a practical approach. Sci. Total Environ. 2000, 247:295-311.
13. Calamari D., Zuccato E., Castiglioni S., Bagnati R., Fanelli R. Strategic survey of therapeutic drugs in the rivers Po and Lambro in northern Italy. Environ. Sci. Technol. 2003, 37:1241-1248.
14. Canesi L., Lorusso L.C., Ciacci C., Betti M., Regoli F., Poiana G., Gallo G., Marcomini A. Effects of blood lipid lowering pharmaceuticals (bezafibrate and gemfibrozil) on immune and digestive gland functions of the bivalve mollusc, Mytilus galloprovincialis. Chemosphere 2007, 69(6):994-1002.
15. Carballa M., Omil F., Lema J.M., Llompart M., García-Jares C., Rodríguez I., Gómez M., Ternes T. Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Res. 2004, 38:2918-2926.
16. Castiglioni S., Fanelli R., Calamari D., Bagnati R., Zuccato E. Methodological approaches for studying pharmaceuticals in the environment by comparing predicted and measured concentrations in River Po, Italy. Regul. Toxicol. Pharm. 2004, 39:25-32.
17. Cravo A., Lopes B., Serafim A., Company R., Barreira L., Gomes T., Bebianno M.J. A multibiomarker approach in Mytilus galloprovincialis to assess environmental quality. J. Environ. Monit. 2009, 11:1673-1686.
18. Cribb A.E., Leeder J.S., Spielberg S.P. Use of a microplate reader in an assay of glutathione reductase using 5,5'-dithiobis(2-nitrobenzoic acid). Anal. Biochem. 1989, 183:195-196.
19. Daughton C.G., Ternes T.A. Pharmaceuticals and health care products in the environment: agents of subtle change?. Environ. Health Persp. 1999, 107(6):907-938.
20. Debska J., Kot-Wasik A., Namiesnik J. Determination of nonsteroidal anti-inflammatory drugs in water samples using liquid chromatography coupled with diode-array detector and mass spectrometry. J. Sep. Sci. 2005, 28:2419-2426.
21. Erdelmeier I., Gerard-Monnier D., Yadan J.C., Acudiere J. Reactions of m-methyl-2-phenlyndole with malondialdehyde and 4-hydroxyalkenals. Mechanistic aspects of the colorimetric assay of lipid peroxidation. Chem. Res. Toxicol. 1998, 11(10):1184-1194.
22. Ericson H., Thorsén G., Kumblad L. Physiological effects of diclofenac, ibuprofen and propranolol on Baltic Sea blue mussels. Aquat. Toxicol. 2010, 99(2):223-231.
23. European Medicines Agency (EMEA) Guideline on the Environmental Risk Assessment of Medicinal Products for Human Use 2006, Committee for Medicinal Products for Human Use, EMEA/CHMP/SWP/4447/00.
24. Farré M.L., Ferrer I., Ginebreda A., Figueras M., Olivella L., Tirapu L., Vilanova M., Barceló D. Determination of drugs in surface water and wastewater samples by liquid chromatography-mass spectrometry: methods and preliminary results including toxicity studies with Vibrio fischeri. J. Chromatogr. A 2001, 938:187-197.
25. Fent K., Weston A., Caminada D. Ecotoxicology of human pharmaceuticals. Aquat. Toxicol. 2006, 76(2):122-159.
26. Fong P.P., Molnar N. Norfluoxetine induces spawning and parturition in estuarine and freshwater bivalves. Bull. Environ. Contam. Toxicol. 2008, 81:535-538.
27. Food and Drug Administration (FDA) Guidance for Industry Environmental Assessment of Human Drug and Biologics Applications 1998, U.S. Department of Health and Human Services, 39.
28. Franzellitti S., Buratti S., Valbonesi P., Capuzzo A., Fabbri E. The β-blocker propranolol affects cAMP-dependent signaling and induces the stress response in Mediterranean mussels, Mytilus galloprovincialis. Aquat. Toxicol. 2011, 101(2):299-308.
29. Gagné F., André C., Gélinas M. Neurochemical effects of benzodiazepine and morphine on freshwater mussels. Comp. Biochem. Physiol. C 2010, 152:207-214.
30. Gagné F., Bérubé E., Fournier M., Blaise C. Inflammatory properties of municipal effluents to Elliptio complanata mussels - lack of effects from anti-inflammatory drugs. Comp. Biochem. Physiol. C 2005, 141:332-337.
31. Gagné F., Blaise C. Estrogenic properties of municipal and industrial wastewaters evaluated with a rapid and sensitive chemoluminescent in situ hybridization assay (CISH) in rainbow trout hepatocytes. Aquat. Toxicol. 1998, 44:83-91.
32. Gagné F., Blaise C., André C. Occurrence of pharmaceutical products in a municipal effluent and toxicity to rainbow trout (Oncorhynchus mykiss) hepatocytes. Ecotoxicol. Environ. Saf. 2006, 64:329-336.
33. Gagné F., Bouchard B., André C., Farcy E., Fournier M. Evidence of feminization in wild Elliptio complanata mussels in the receiving waters downstream of a municipal effluent outfall. Comp. Biochem. Phys. C 2011, 153:99-106.
34. Gagné F., Blaise C., André C., Gagnon C., Salazar M. Neuroendocrine disruption and health effects in Elliptio complanata mussels exposed to aeration lagoons for wastewater treatment. Chemosphere 2007, 68:731-743.
35. Gagné F., Blaise C., Pellerin J., Gauthier-Clerc S. Alteration of the biochemical properties of female gonads and vitellins in the clam Mya arenaria at contaminated sites in the Saguenay Fjord. Mar. Environ. Res. 2002, 53:295-310.
36. Gagné F., Blaise C., Salazar M., Salazar S., Hansen P.D. Evaluation of estrogenic effects of municipal effluents to the freshwater mussel Elliptio complanata. Comp. Biochem. Physiol. C 2001, 128:213-225.
37. Gonzalez-Rey M., Bebianno M.J. Non-steroidal anti-inflammatory drug (NSAID) Ibuprofen distresses antioxidant defense system in mussel Mytilus galloprovincialis gills. Aquat. Toxicol. 2011, 105:264-269.
38. Greenwald R.A. Handbook of Methods for Oxygen Radical Research 1985, CRC Press, Boca Raton, FL, USA.
39. Gros M., Petrović M., Barceló D. Development of a multi-residue analytical methodology based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) for screening and trace level determination of pharmaceuticals in surface and wastewaters. Talanta 2006, 70(4):678-690.
40. Habig W.H., Pabst M.J., Jakoby W.B. Glutathione-S-transferases - the first enzymatic step in mercapturic acid formation. J. Biol. Chem. 1974, 249:7130-7139.
41. Halling-Sørensen B., Nielsen S.N., Lanzky P.F., Ingerslev F., Lutzhoft H.C.H., Jorgensen S.E. Occurrence, fate and effects of pharmaceutical substances in the environment - a review. Chemosphere 1998, 36:357-394.
42. Hernando M.D., Mezcua M., Fern A.R., Barceló D. Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. Talanta 2006, 69:334-342.
43. Huang Q., Yu Y., Tang C., Zhang K., Cui J., Peng X. Occurrence and behavior of non-steroidal anti-inflammatory drugs and lipid regulators in wastewater and urban river water of the Pearl River Delta, South China. J. Environ. Monitor. 2011, doi:10.1039/C1EM10015G.
44. INFARMED Autoridade nacional do medicamento e produtos de saúde/National Authority for Pharmaceutical and Health Products Vendas de medicamentos não sujeitos a receita médica fora das farmácias (MNSRM)/Pharmaceutical Sold Without Medical Prescription Outside Pharmacies 2008, Ministry of Health, Portugal.
45. Kasprzyk-Hordern B., Dinsdale R.M., Guwy A.J. The effect of signal suppression and mobile phase composition on the simultaneous analysis of multiple classes of acidic/neutral pharmaceuticals and personal care products in surface water by solid-phase extraction and ultra performance liquid chromatography-negative electrospray tandem mass spectrometry. Talanta 2008, 74:1299-1312.
46. Kim S.D., Cho J., Kim I.S., Vanderford B.J., Snyder S.A. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters. Water Res. 2007, 41:1013-1021.
47. Kolpin D.W., Furlong E.T., Meyer M.T. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. Environ. Sci. Technol. 2002, 36:1202-1211.
48. Lissemore L., Hao C., Yang P., Sibley P.K., Mabury S., Solomon K.R. An exposure assessment for selected pharmaceuticals within a watershed in Southern Ontario. Chemosphere 2006, 64(5):717-729.
49. Martín-Díaz L., Franzellitti S., Buratti S., Valbonesi P., Capuzzo A., Fabbri E. Effects of environmental concentrations of the antiepilectic drug carbamazepine on biomarkers and cAMP-mediated cell signaling in the mussel Mytilus galloprovincialis. Aquat. Toxicol. 2009, 94(3):177-185.
50. Martín-Díaz L., Gagné F., Blaise C. The use of biochemical responses to assess ecotoxicological effects of pharmaceutical and personal care products (PPCPs) after injection in the mussel Elliptio complanata. Environ. Toxicol. Phar. 2009, 28:237-242.
51. Matozzo V., Gagné F., Marin M.G., Ricciardi F., Blaise C. Vitellogenin as a biomarker of exposure to estrogenic compounds in aquatic invertebrates: a review. Environ. Int. 2008, 34:531-545.
52. Matozzo V., Marin M.G. Can 17-ß estradiol induce vitellogenin-like proteins in the clam Tapes philippinarum?. Environ. Toxicol. Phar. 2008, 26:38-44.
53. McCord J.M., Fridovich I. Superoxide dismutase: an enzymatic function for erythrocuprein (hemocuprein). J. Biol. Chem. 1969, 244(22):6049-6055.
54. Metcalfe C.D., Koenig B.G., Bennie D.T., Servos M., Ternes T.A., Hirsch R. Occurrence of neutral and acidic drugs in the effluents of Canadian sewage treatment plants. Environ. Toxicol. Chem. 2003, 22(12):2872-2880.
55. Moeder M., Schrader S., Winkler M., Popp P. Solid-phase microextraction-gas chromatography-mass spectrometry of biologically active substances in water samples. J. Chromatogr. A 2000, 873:95-106.
56. Moldovan Z. Occurrences of pharmaceutical and personal care products as micropollutants in rivers from Romania. Chemosphere 2006, 64(11):1808-1817.
57. Öllers S., Singer H.P., Fassler P., Muller S.R. Simultaneous quantification of neutral and acidic pharmaceuticals and pesticides at the low-ng/l level in surface and waste water. J. Chromatogr. A 2001, 911(2):225-234.
58. Ortiz-Zarragoitia M., Cajaraville M.P. Biomarkers of exposure and reproduction-related effects in mussels exposed to endocrine disruptors. Arch. Environ. Contam. Toxicol. 2006, 50(3):361-369.
59. Osada M., Nomura T. The levels of reproductive cycle prostaglandins associated with the of the scallop, Patinopecten yessoensis. Prostaglandins 1990, 40(3):229-239.
60. Pailler J.-Y., Krein A., Pfister L., Hoffmann L., Guignard C. Solid phase extraction coupled to liquid chromatography-tandem mass spectrometry analysis of sulfonamides, tetracyclines, analgesics and hormones in surface water and wastewater in Luxembourg. Sci. Total. Environ. 2009, 407:4736-4743.
61. Parolini M., Binelli A., Cogni D., Provini A. Multi-biomarker approach for the evaluation of the cyto-genotoxicity of paracetamol on the zebra mussel (Dreissena polymorpha). Chemosphere 2010, 79(5):489-498.
62. Parolini M., Binelli A., Cogni D., Riva C., Provini A. An in vitro biomarker approach for the evaluation of the ecotoxicity of non-steroidal anti-inflammatory drugs (NSAIDs). Toxicol. In Vitro 2009, 23(5):935-942.
63. Porte C., Janer G., Lorusso L.C., Ortiz-Zarragoitia M., Cajaraville M.P., Fossi M.C., Canesi L. Endocrine disruptors in marine organisms: approaches and perspectives. Comp. Biochem. Physiol. C 2006, 143(3):303-315.
64. Praveen Rao P.N., Knaus E.E. Evolution of nonsteroidal anti-inflammatory cyclooxygenase (COX) inhibition and beyond drugs (NSAIDs). North 2008, 11(2):81-110.
65. Regoli F., Gorbi S., Frenzilli G., Nigro M., Corsi I., Focardi S., Winston G.W. Oxidative stress in ecotoxicology: from analysis of individual antioxidants to a more integrated approach. Mar. Environ. Res. 2002, 54:419-423.
66. Regoli F., Pellegrini D., Winston G.W., Gorbi S., Giuliani S., Virno-Lamberti C., Bompadre S. Application of biomarkers for assessing the biological impact of dredged materials in the Mediterranean: the relationship between antioxidant responses and susceptibility to oxidative stress in the red mullet (Mullus barbatus). Mar. Pollut. Bull. 2002, 44:912-922.
67. Reif R., Suárez S., Omil F., Lema J.M. Fate of pharmaceuticals and cosmetic ingredients during the operation of a MBR treating sewage. Desalination 2008, 221:511-517.
68. Roberts P.H., Thomas K.V. The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. Sci. Total Environ. 2006, 356(1-3):143-153.
69. Rowley A.F., Vogan C.L., Taylor G.W., Clare A.S. Prostaglandins in non insectan invertebrates: recent insights and unsolved problems. J. Exp. Biol. 2005, 208:3-14.
70. Ruggeri B., Thoroughgood C.A. Prostaglandins in aquatic fauna: a comprehensive review. Mar. Ecol. Prog. Ser. 1985, 23:301-306.
71. Solé M., Shaw J.P., Frickers P.E., Weadman J.W., Hutchinson T.H. Effects on feeding rate and biomarker responses of marine mussels experimentally exposed to propranolol and acetaminophen. Anal. Bioanal. Chem. 2010, 396(2):649-656.
72. Stanton M.G. Colorimetric determination of inorganic phosphate in the presence of biological material and adenosine triphosphate. Anal. Biochem. 1968, 22:27-34.
73. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 1998, 32(11):3245-3260.
74. Thomas K.V., Hilton M.J. The occurrence of selected human pharmaceutical compounds in UK estuaries. Mar. Pollut. Bull. 2004, 49:436-444.
75. Tixier C., Singer H.P., Foellers S., Müller S.R. Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters. Environ. Sci. Tech. 2003, 37(6):1061-1068.
76. Togola A., Budzinski H. Multi-residue analysis of pharmaceutical compounds in aqueous samples. J. Chromatogr. A 2008, 1177(1):150-158.
77. Van der Ven K., Keil D., Moens L.N., Van Hummelen P., Van Remortel P., Maras M., De Coen W. Effects of the antidepressant mianserin in zebrafish: molecular markers of endocrine disruption. Chemosphere 2006, 65(10):1836-1845.
78. Vane J.R., Bakhle Y.S., Botting R.M. Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. 1998, 38:97-120.
79. Viarengo A., Canesi L., Garcia Martinez P., Peters L.D., Livingstone D.R. Pro-oxidant processes and antioxidant defence systems in the tissues of the Antarctic scallop (Adamussium colbecki) compared with the Mediterranean scallop (Pecten jacobaeus). Comp. Biochem. Physiol. B 1995, 111(1):119-126.
80. Wang L., Ying G.-G., Zhao J.-L., Yang X.-B., Chen F., Tao R., Liu S., Zhou L.-J. Occurrence and risk assessment of acidic pharmaceuticals in the Yellow River, Hai River and Liao River of north China. Sci. Total Environ. 2010, 408:3139-3147.
81. Weigel S., Berger U., Jensen E., Kallenborn R., Thoresen H., Hühnerfuss H. Determination of selected pharmaceuticals and caffeine in sewage and seawater from Tromsø/Norway with emphasis on ibuprofen and its metabolites. Chemosphere 2004, 56:583-592.
82. Yoon Y., Ryu J., Oh J., Choi B.-G., Snyder S. Occurrence of endocrine disrupting compounds, pharmaceuticals, and personal care products in the Han River (Seoul, South Korea). Sci. Total Environ. 2010, 408(3):636-643.
83. Zar J.H. Biostatistical Analysis 1999, Prentice Hall International, Inc., USA. 4th ed.
84. Zhang S., Zhang Q., Shameka Darisaw S., Ehie O., Wang G. Simultaneous quantification of polycyclic aromatic hydrocarbons (PAHs), polychlorinated biphenyls (PCBs), and pharmaceuticals and personal care products (PPCPs) in Mississippi river water, in New Orleans, Louisiana, USA. Chemosphere 2007, 66:1057-1069.
85. Zuccato E., Castiglioni S., Fanelli R. Identification of the pharmaceuticals for human use contaminating the Italian aquatic environment. J. Hazard. Mater. 2005, 122:205-209.